Fast Track Group (CRNX) compared with its closest peers (CATX, PGEN, CTNM, OVID, OLMA). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Perspective Therapeutics, Precigen, Contineum Therapeutics, Ovid Therapeutics, Olema Pharmaceuticals, Bolt Biotherapeutics, Whitehawk Therapeutics, Crescent Biopharma, Rapport Therapeutics and BioAge Labs share Crinetics Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | $321.91M | — |
| Precigen, Inc. (PGEN) | $2.45B | — |
| Contineum Therapeutics, Inc. (CTNM) | $554.52M | — |
| Ovid Therapeutics Inc. (OVID) | $523.40M | — |
| Olema Pharmaceuticals, Inc. (OLMA) | $787.48M | — |
| Bolt Biotherapeutics, Inc. (BOLT) | $7.40M | — |
| Whitehawk Therapeutics, Inc. (WHWK) | $203.74M | — |
| Crescent Biopharma, Inc. (CBIO) | $717.99M | — |
| Rapport Therapeutics, Inc. (RAPP) | $2.09B | — |
| BioAge Labs, Inc. (BIOA) | $390.12M | — |
CRNX overview · CRNX earnings · CRNX financials · CRNX KPIs · CRNX documents · CRNX ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.